2 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow XEN45: new trials by email Literature Review of XEN45 trials Research Report on XEN45
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation XEN45 - Glaucoma, Endothelial Cell Loss, Corneal | Completed | Paracelsus Medical University | 129 | 2020-01-30 | 2021-07-13 | |
| Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma XEN45 - Glaucoma, Angle-Closure | Phase 3 | Completed | Allergan | 65 | 2018-07-19 | 2023-05-17 |
Glaucoma (2) · Corneal Endothelial Cell Loss (1)
Allergan (1) · Paracelsus Medical University (1)
Australia (1) · Austria (1) · Canada (1) · Singapore (1) · South Korea (1) · Taiwan (1) · United Kingdom (1)